Treatments for sore throat linked to acute pharyngitis and viral tonsillitis
Official title: Evaluation of Treatments for Sore Throat Associated With Acute Pharyngitis and/or Viral Tonsillitis
Run by University Hospital, Clermont-Ferrand · NCT07569939 · Data updated 2026-11-12
This post-marketing follow-up checks four products (HMG, PHN, PHR, TUR) in people with sore throats from acute pharyngitis or viral tonsillitis to see if they are safe and helpful in real-world use.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 160 (estimated) |
| Sponsor | University Hospital, Clermont-Ferrand Academic / other |
| Locations | 1 site (Clermont-Ferrand) |
| Status | Recruiting |
| Started | July 29, 2026 |
| Main results expected | January 2028 |
| Study ends | January 2028 |
| Registry record updated | August 5, 2026 |
| Trial ID | NCT07569939 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults and eligible female patients of childbearing potential who have acute sore throat onset within 72 hours and are affiliated with the French Social Security system, able to consent and follow study procedures.
✕Probably not a fit
Patients with severe complications, confirmed influenza/COVID-19 requiring specific treatment, or those with hypersensitivity to any product components may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study collects real-world clinical data to monitor the tolerance, safety, and efficacy of four medical devices used for sore throat related to acute pharyngitis and viral-origin tonsillitis. It is an observational, post-marketing follow-up rather than a randomized trial. Participants must have sore throat with onset within 72 hours and meet specific inclusion criteria, while excluding those with certain infections or allergies. Data are gathered in routine clinical settings to assess risk/benefit in typical use. The lead sponsor is University Hospital, Clermont-Ferrand, with participation at Chu Clermont Ferrand in Clermont-Ferrand, France.
Why it matters
Potential benefit: If successful, the study could confirm that these devices are safe and helpful for patients with sore throats from viral or acute pharyngitis origins in real-world use.
How similar studies have gone: Previous post-marketing follow-ups have shown variable safety and performance for similar devices in real-world sore throat management; this study aims to corroborate their tolerability and efficacy.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pharyngitis or tonsillitis or acute nasopharyngitis or viral-origin sore throat with odynophagia that began less than 72 hours before the inclusion visit according to the investigator's judgment * Bacterial rhinopharyngitis with negative TROD test * Effective contraception for female patients of childbearing age * Cooperation and sufficient understanding to comply with the requirements of the trial * Acceptance of registration in the SI-RIPH database * Having received informed information and agreeing to give written consent * Affiliated with the French Social Security scheme. Exclusion Criteria: * Hypersensitivity/previous allergy to any of the product components, * Pharyngitis or tonsillitis or acute rhinopharyngitis complicated (phlegmon, acute otitis media, pneumonia…) or severely intolerable cough, * Positive antigen test for influenza A/B or COVID-19 and infection requiring etiological treatment according to the recommendations, * Other ongoing treatments for acute pharyngitis or tonsillitis (local treatment, antibiotics, corticosteroids, antiretroviral…), * Comorbidities or health conditions deemed incompatible with the trial by the investigator, * Recent otorhinolaryngology surgery (\<6 months), * Pulmonary pathology (Chronic Obstructive Pulmonary Disease, asthma…), * Immunosuppression (according to patient's report), * Pregnant or breastfeeding women, * Currently participating in another clinical trial, or in the exclusion period, or having received total compensation of more than €6,000 in the 12 months prior to the start of the trial, * Benefiting from legal protection measures (guardianship, trusteeship, deprivation of liberty, judicial protection).
Where it's running
-
Chu Clermont Ferrand
Clermont-Ferrand, France Recruiting
Study contacts
- Study coordinator: Lise Laclautre
- Email: promo_interne_drci@chu-clermontferrand.fr
- Phone: +33473754963
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Qinqiao Yan Shu Granules for treating acute pharyngitis
This study is testing if Qinqiao Yan Shu Granules can help people with acute pharyngitis feel better compared to a very low dose of the treatment.
-
Evaluating Graminidin with Anesthetic for Treating Sore Throat
This study is testing a new throat spray called Graminidin with anesthetic to see if it helps people with sore throats feel better compared to a popular throat lozenge.
-
Nebulized Dexmedetomidine vs Nebulized Lidocaine for Postoperative Sore Throat in Children
This study tests whether inhaled dexmedetomidine reduces sore throat after tonsil removal in children, compared with inhaled lidocaine.
-
OROSEDAL use in sore throat and minor oral lesions
This is a real-world, non-interventional study checking how well OROSEDAL works and how safe it is in people aged 8 and older who have sore throats or small mouth lesions in routine clinical practice.
-
Suctioning the breathing tube versus skipping suctioning when waking from general anesthesia
This tests whether skipping suctioning of the breathing tube right before removal is as safe for adults (18–90) having elective surgery under general anesthesia.
-
Comparing different tracheal catheters for women undergoing thyroid surgery
This study is testing which size of tracheal catheter causes the least sore throat after thyroid surgery in women.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.